1,10-phenanthroline increases expression EXP 6480464 1, 10-phenanthroline results in increased expression of HILPDA mRNA CTD PMID:19502547 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1619151 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HILPDA mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1619151 6480464 Tetrachlorodibenzodioxin results in increased expression of HILPDA mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1619151 6480464 Tetrachlorodibenzodioxin affects the expression of HILPDA mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2319900 6480464 Tetrachlorodibenzodioxin results in increased expression of HILPDA mRNA CTD PMID:26232522 2-butoxyethanol increases expression ISO RGD:1619151 6480464 n-butoxyethanol results in increased expression of HILPDA mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of HILPDA mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of HILPDA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HILPDA mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of HILPDA mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:1619151 6480464 Fenretinide results in increased expression of HILPDA mRNA CTD PMID:28973697 6alpha-methylprednisolone decreases expression EXP 6480464 Methylprednisolone results in decreased expression of HILPDA mRNA CTD PMID:19192274 acetaldehyde decreases expression EXP 6480464 Acetaldehyde results in decreased expression of HILPDA mRNA CTD PMID:23416264 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of HILPDA mRNA CTD PMID:15725085 atrazine increases expression EXP 6480464 Atrazine results in increased expression of HILPDA mRNA CTD PMID:22378314 azathioprine decreases expression EXP 6480464 Azathioprine results in decreased expression of HILPDA mRNA CTD PMID:19192274 benzo[a]pyrene decreases expression ISO RGD:1619151 6480464 Benzoapyrene results in decreased expression of HILPDA mRNA CTD PMID:21569818 , PMID:22610609 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of HILPDA mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of HILPDA promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1619151 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in decreased expression of HILPDA mRNA CTD PMID:27858113 benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene decreases expression ISO RGD:1619151 6480464 benzobfluoranthene results in decreased expression of HILPDA mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1619151 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in decreased expression of HILPDA mRNA CTD PMID:27858113 Benzo[k]fluoranthene decreases expression ISO RGD:1619151 6480464 benzokfluoranthene results in decreased expression of HILPDA mRNA CTD PMID:26377693 bisphenol F multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HILPDA mRNA CTD PMID:28628672 butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of HILPDA mRNA CTD PMID:26079696 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of HILPDA mRNA CTD PMID:21120746 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of HILPDA mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1619151 6480464 Nanotubes, Carbon results in increased expression of HILPDA mRNA CTD PMID:25620056 carbon nanotube affects expression ISO RGD:1619151 6480464 Nanotubes more ... CTD PMID:25554681 celastrol decreases expression EXP 6480464 tripterine results in decreased expression of HILPDA mRNA CTD PMID:17010675 chromium(6+) affects expression ISO RGD:1619151 6480464 chromium hexavalent ion affects the expression of HILPDA mRNA CTD PMID:28472532 chrysene multiple interactions ISO RGD:1619151 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in decreased expression of HILPDA mRNA CTD PMID:27858113 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of HILPDA mRNA CTD PMID:27392435 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of HILPDA mRNA CTD PMID:27392435 clofibrate increases expression ISO RGD:1619151 6480464 Clofibrate results in increased expression of HILPDA mRNA CTD PMID:23811191 , PMID:25270620 cobalt dichloride multiple interactions EXP 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HILPDA mRNA] CTD PMID:22202117 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of HILPDA mRNA CTD PMID:22202117 cobalt(2+) sulfate increases expression EXP 6480464 cobalt sulfate results in increased expression of HILPDA mRNA CTD PMID:19502547 copper atom multiple interactions ISO RGD:1619151 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HILPDA mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1619151 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HILPDA mRNA CTD PMID:15467011 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of HILPDA mRNA CTD PMID:19549813 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of HILPDA mRNA CTD PMID:20106945 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of HILPDA mRNA CTD PMID:25562108 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of HILPDA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HILPDA mRNA CTD PMID:28628672 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of HILPDA mRNA CTD PMID:15725085 dibenz[a,h]anthracene decreases expression ISO RGD:1619151 6480464 1 more ... CTD PMID:26377693 dibenzo[a,l]pyrene decreases expression ISO RGD:1619151 6480464 dibenzoa, lpyrene results in decreased expression of HILPDA mRNA CTD PMID:25908611 dichloroacetic acid increases expression ISO RGD:1619151 6480464 Dichloroacetic Acid results in increased expression of HILPDA mRNA CTD PMID:28962523 dioxygen increases expression ISO RGD:1619151 6480464 Oxygen deficiency results in increased expression of HILPDA mRNA CTD PMID:20880076 dioxygen multiple interactions ISO RGD:1619151 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HILPDA mRNA CTD PMID:30529165 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of HILPDA mRNA CTD PMID:19502547 more ... dioxygen multiple interactions EXP 6480464 1-cyclopropyl-4-4-5-methyl-3-3-4-trifluoromethoxyphenyl-1 more ... CTD PMID:24403227 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of HILPDA mRNA CTD PMID:22908232 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of HILPDA mRNA CTD PMID:23378141 ethanol multiple interactions ISO RGD:1619151 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of HILPDA mRNA CTD PMID:30517762 ferric oxide increases expression ISO RGD:1619151 6480464 ferric oxide analog results in increased expression of HILPDA mRNA CTD PMID:25086211 folic acid multiple interactions EXP 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of HILPDA mRNA CTD PMID:23378141 folic acid decreases expression ISO RGD:1619151 6480464 Folic Acid results in decreased expression of HILPDA mRNA CTD PMID:25629700 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of HILPDA mRNA CTD PMID:20655997 gedunin decreases expression EXP 6480464 gedunin results in decreased expression of HILPDA mRNA CTD PMID:17010675 hexadecanoic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of HILPDA protein, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of HILPDA protein CTD PMID:30547786 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of HILPDA mRNA CTD PMID:20044591 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of HILPDA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HILPDA mRNA CTD PMID:28628672 isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of HILPDA mRNA CTD PMID:20436886 lead diacetate increases expression ISO RGD:1619151 6480464 lead acetate results in increased expression of HILPDA mRNA CTD PMID:21829687 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of HILPDA mRNA CTD PMID:28988120 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of HILPDA mRNA CTD PMID:21092101 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of HILPDA mRNA CTD PMID:21092101 manganese(II) chloride increases expression ISO RGD:2319900 6480464 manganese chloride results in increased expression of HILPDA mRNA CTD PMID:22281203 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of HILPDA mRNA CTD PMID:19192274 motexafin gadolinium increases expression EXP 6480464 motexafin gadolinium results in increased expression of HILPDA mRNA CTD PMID:16357179 motexafin gadolinium multiple interactions EXP 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HILPDA mRNA CTD PMID:16357179 N-nitrosodiethylamine increases expression ISO RGD:1619151 6480464 Diethylnitrosamine results in increased expression of HILPDA mRNA CTD PMID:24535843 naphthalene increases expression ISO RGD:1619151 6480464 naphthalene results in increased expression of HILPDA mRNA CTD PMID:18978301 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of HILPDA mRNA CTD PMID:24768652 nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of HILPDA mRNA CTD PMID:21455298 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of HILPDA mRNA CTD PMID:17382205 oleic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of HILPDA protein, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of HILPDA protein CTD PMID:30547786 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of HILPDA mRNA CTD PMID:29067470 pentanal decreases expression EXP 6480464 pentanal results in decreased expression of HILPDA mRNA CTD PMID:26079696 pioglitazone multiple interactions EXP 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA, pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA] CTD PMID:20847119 pirinixic acid multiple interactions ISO RGD:1619151 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of HILPDA mRNA, PPARA protein affects the reaction [pirinixic acid results in increased expression of HILPDA mRNA] CTD PMID:20813756 , PMID:21318169 pirinixic acid increases expression ISO RGD:1619151 6480464 pirinixic acid results in increased expression of HILPDA mRNA CTD PMID:20813756 , PMID:21318169 piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of HILPDA mRNA CTD PMID:19192274 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of HILPDA mRNA CTD PMID:21632981 quinolin-8-ol decreases expression EXP 6480464 Oxyquinoline results in decreased expression of HILPDA mRNA CTD PMID:21632981 rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of HILPDA mRNA CTD PMID:30851411 resorcinol increases expression EXP 6480464 resorcinol results in increased expression of HILPDA mRNA CTD PMID:22623647 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of HILPDA mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1619151 6480464 Silicon Dioxide results in increased expression of HILPDA mRNA CTD PMID:19073995 silver atom affects expression ISO RGD:1619151 6480464 Silver affects the expression of HILPDA mRNA CTD PMID:27131904 silver(0) affects expression ISO RGD:1619151 6480464 Silver affects the expression of HILPDA mRNA CTD PMID:27131904 sodium aurothiomalate decreases expression EXP 6480464 Gold Sodium Thiomalate results in decreased expression of HILPDA mRNA CTD PMID:19192274 sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of HILPDA mRNA CTD PMID:31533062 tert-butyl hydroperoxide multiple interactions EXP 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of HILPDA mRNA CTD PMID:20847119 tetrachloromethane increases expression ISO RGD:1619151 6480464 Carbon Tetrachloride results in increased expression of HILPDA mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions ISO RGD:1619151 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of HILPDA mRNA CTD PMID:30517762 tetraphene multiple interactions ISO RGD:1619151 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in decreased expression of HILPDA mRNA CTD PMID:27858113 troglitazone multiple interactions EXP 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA, troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA] CTD PMID:20847119 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of HILPDA mRNA CTD PMID:22378314 urethane decreases expression EXP 6480464 Urethane results in decreased expression of HILPDA mRNA CTD PMID:28818685 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of HILPDA mRNA CTD PMID:23179753 vandetanib increases expression EXP 6480464 N-4-bromo-2-fluorophenyl-6-methoxy-7-1-methylpiperidin-4-ylmethoxyquinazolin-4-amine results in increased expression of HILPDA mRNA CTD PMID:16052530 vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of HILPDA mRNA CTD PMID:23649840 zinc acetate multiple interactions EXP 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HILPDA mRNA CTD PMID:16357179 zinc acetate increases expression EXP 6480464 Zinc Acetate results in increased expression of HILPDA mRNA CTD PMID:16357179 zinc dichloride multiple interactions EXP 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HILPDA mRNA] CTD PMID:22202117 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of HILPDA mRNA CTD PMID:16330358
